Titan Medical Inc.(Us) (TSE:TMD) has released an update.
Titan Medical Inc. is progressing with its planned all-stock merger with Conavi Medical Inc., aiming to expand the commercialization of Conavi’s Novasight Hybrid System for minimally invasive coronary procedures. The companies are working towards meeting the merger conditions, which include seeking TSX Venture Exchange listing approvals, preparing for Titan’s shareholder meeting to approve the deal, and arranging a concurrent financing round for Conavi aiming to raise between $15 to $20 million.
For further insights into TSE:TMD stock, check out TipRanks’ Stock Analysis page.
